Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153451 · ClinicalTrials.gov registry record · NA
An Automatic Notification System for Test Results Finalized After Discharge
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 441
- Enrollment target
NCT01153451: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT01153451 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 441 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01153451, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 441 participants
- Enrollment target
Study Summary
Specific Aims: (Study #1, funded by AHRQ, completed May 2011) 1. To create an automatic notification system to prompt physicians of test results finalized after discharge. 2. To evaluate the impact of this system on physician awareness of test results finalized after discharge. Hypothesis: Automatic email notification will improve physician awareness of test results finalized after discharge compared to usual care. Specific Aims: (Study #2, funded by CRICO, completed July 2012) 1. To identify a cohort of discharged patients with potentially actionable results of tests pending at discharge (TPAD). 2. To determine if automated email notification of the finalized results of potentially actionable TPADs affects the rate of post-discharge actions taken as documented in the electronic medical record (EMR). Hypothesis: Automated email notification of the finalized results of potentially actionable TPADs increases the rate of actions taken post-discharge.
Primary Outcome
The primary outcome will be the percentage of inpatient physicians who are aware of the finalized results of tests pending at discharge.
Interventions
- OTHER Email Notification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 441 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-07 |
| Phase | NA |
What the finished NCT01153451 record still lists
NCT01153451 is an interventional study that assigns participants to a tested intervention. The registered 441 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 1 intervention - of which Email Notification is the first listed.
NCT01153451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01153451 about?
NCT01153451 is a clinical study titled "An Automatic Notification System for Test Results Finalized After Discharge". Specific Aims: (Study #1, funded by AHRQ, completed May 2011) 1. To create an automatic notification system to prompt physicians of test results finalized after discharge. 2. To evaluate the impact of this system on physician awareness of test results finalized after discharge. Hypothesis: Automat...
What is the current status of trial NCT01153451?
This trial is currently completed. It is a NA study. The enrollment target is 441 participants. The study started on 2010-10. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01153451?
The interventions under investigation include: Email Notification (OTHER).
Who is sponsoring clinical trial NCT01153451?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01153451's enrollment target sits among peer trials
441 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02679144 · 441 participants · Phase 2
Neuroblastoma Maintenance Therapy Trial
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia